Recruiting Hypertension Studies in Torrance
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
This study will evaluate the efficacy of TNX-103 (oral levosimendan) compared with placebo in subjects with PH-HFpEF as measured by the change in 6-Minute Walk Distance (6 MWD; Day 1 to Week 12)....
A Study of Mosliciguat in PH-ILD
This is a Phase 2, randomized, double-blind, placebo-controlled, multi-center clinical study to evaluate the safety and efficacy of inhaled mosliciguat in participants with pulmonary hypertension asso...
About Hypertension Clinical Trials in Torrance
Hypertension, or high blood pressure, is a common condition that increases the risk of heart disease, stroke, and kidney damage. Often called the "silent killer" because it usually has no symptoms. Management includes lifestyle modifications and medications to lower blood pressure.
There are currently 2 hypertension clinical trials recruiting participants in Torrance, CA. These studies are seeking a combined 350 participants. Research is being sponsored by Tenax Therapeutics, Inc., Pulmovant, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hypertension Clinical Trials in Torrance — FAQ
Are there hypertension clinical trials in Torrance?
Yes, there are 2 hypertension clinical trials currently recruiting in Torrance, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Torrance?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Torrance research site will contact you about next steps.
Are clinical trials in Torrance free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Torrance studies also compensate for your time and travel.
What hypertension treatments are being tested?
The 2 active trials in Torrance are testing new therapies including novel drugs, biologics, and treatment approaches for hypertension.
Data updated March 2, 2026 from ClinicalTrials.gov